Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

The use of intravenous palivizumab for treatment of persistent RSV infection in children with leukemia.

Santos RP, Chao J, Nepo AG, Butt S, Stellrecht KA, Pearce JM, Lepow ML.

Pediatrics. 2012 Dec;130(6):e1695-9. doi: 10.1542/peds.2011-1768. Epub 2012 Nov 12.

PMID:
23147965
2.

Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.

Ghedin E, Laplante J, DePasse J, Wentworth DE, Santos RP, Lepow ML, Porter J, Stellrecht K, Lin X, Operario D, Griesemer S, Fitch A, Halpin RA, Stockwell TB, Spiro DJ, Holmes EC, St George K.

J Infect Dis. 2011 Jan 15;203(2):168-74. doi: 10.1093/infdis/jiq040.

3.

Advances in virology--Weller and Robbins.

Lepow ML.

N Engl J Med. 2004 Oct 7;351(15):1483-5. No abstract available.

PMID:
15470208
4.

Meningococcal immunology.

Lepow ML, Hughes PA.

Immunol Allergy Clin North Am. 2003 Nov;23(4):769-86. Review.

PMID:
14753391
5.

The impact of an enteroviral RT-PCR assay on the diagnosis of aseptic meningitis and patient management.

Stellrecht KA, Harding I, Woron AM, Lepow ML, Venezia RA.

J Clin Virol. 2002 Jul;25 Suppl 1:S19-26.

PMID:
12091078
6.

A one-step RT-PCR assay using an enzyme-linked detection system for the diagnosis of enterovirus meningitis.

Stellrecht KA, Harding I, Hussain FM, Mishrik NG, Czap RT, Lepow ML, Venezia RA.

J Clin Virol. 2000 Sep 1;17(3):143-9.

PMID:
10996110
7.

Potential mechanisms for failure to eradicate group A streptococci from the pharynx.

Gerber MA, Tanz RR, Kabat W, Bell GL, Siddiqui Bp, Lerer TJ, Lepow ML, Kaplan EL, Shulman ST.

Pediatrics. 1999 Oct;104(4 Pt 1):911-7.

PMID:
10506234
8.

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.

Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA.

Pediatrics. 1997 Mar;99(3):454-61.

PMID:
9041304
9.

Candida albicans arthritis one year after successful treatment of fungemia in a healthy infant.

Swanson H, Hughes PA, Messer SA, Lepow ML, Pfaller MA.

J Pediatr. 1996 Nov;129(5):688-94. Review.

PMID:
8917235
10.
11.

Measles antibodies in women and infants in the vaccine era.

Kacica MA, Venezia RA, Miller J, Hughes PA, Lepow ML.

J Med Virol. 1995 Feb;45(2):227-9.

PMID:
7775944
12.

Prevention of gram-positive sepsis in neonates weighing less than 1500 grams.

Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA.

J Pediatr. 1994 Aug;125(2):253-8.

PMID:
8040775
13.

Meningitis: clinical presentation and workup.

Kacica MA, Lepow ML.

Pediatr Ann. 1994 Feb;23(2):69-70, 73-5. No abstract available.

PMID:
8196983
14.

Correlation between antibody affinity and serum bactericidal activity in infants.

Hetherington SV, Lepow ML.

J Infect Dis. 1992 Apr;165(4):753-6.

PMID:
1552207
15.

Measles vaccine and measles control.

Lepow ML.

Pediatr Ann. 1990 Sep;19(9):543-5, 548-50. Review. No abstract available.

PMID:
2235110
16.

Haemophilus influenzae type b vaccines: lessons from the past.

Daum RS, Marcuse EK, Giebink GS, Hall CB, Lepow ML, McCracken GH Jr, Peter G, Phillips CF, Wright HT Jr, Plotkin SA.

Pediatrics. 1988 Jun;81(6):893-7. No abstract available.

PMID:
3259308
17.

Persistence of antibody to Haemophilus influenzae type b at 4 years of age in children previously immunized with polysaccharide antigen alone or conjugated with diphtheria toxoid.

Lepow ML, Cimma R, Larsen D, Schumacher J, Rogan M, Randolph M, Gaintner S, Samuelson J, Gordon L.

J Pediatr. 1988 May;112(5):741-2. No abstract available.

PMID:
3361383
18.

Vaccination of 18-month-old children with conjugated polyribosyl ribitol phosphate stimulates production of functional antibody to Haemophilus influenzae type b.

Musher DM, Watson DA, Lepow ML, McVerry P, Hamill R, Baughn RE.

Pediatr Infect Dis J. 1988 Mar;7(3):156-9.

PMID:
3258660
19.

Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.

Lepow ML, Barkin RM, Berkowitz CD, Brunell PA, James D, Meier K, Ward J, Zahradnik JM, Samuelson J, McVerry PH, et al.

J Infect Dis. 1987 Oct;156(4):591-6.

PMID:
3497990
20.

Epidemiology and immunology of Hemophilus influenzae type B infections in childhood: implications for chemoprophylaxis and immunization.

Hetherington S, Lepow ML.

Adv Pediatr Infect Dis. 1987;2:1-18. Review. No abstract available.

PMID:
3331279
21.

Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children.

Lepow ML, Beeler J, Randolph M, Samuelson JS, Hankins WA.

J Infect Dis. 1986 Dec;154(6):1033-6. No abstract available.

PMID:
3097160
22.

Cephalhematoma complicated by osteomyelitis presumed due to Gardnerella vaginalis.

Nightingale LM, Eaton CB, Fruehan AE, Waldman JB, Clark WB, Lepow ML.

JAMA. 1986 Oct 10;256(14):1936-7. No abstract available.

PMID:
3489841
23.

Aplastic anemia following chloramphenicol therapy still happens!

Lepow ML.

Pediatrics. 1986 Jun;77(6):932-3. No abstract available.

PMID:
3714393
24.

Progressive varicella in three patients with Wiskott-Aldrich syndrome: treatment with adenine arabinoside.

Wade NA, Lepow ML, Veazey J, Meuwissen HJ.

Pediatrics. 1985 Apr;75(4):672-5.

PMID:
3982899
25.
27.
28.

Response of infants to Haemophilus influenzae type b polysaccharide and diphtheria-tetanus-pertussis vaccines in combination.

Lepow ML, Peter G, Glode MP, Daum RS, Calnen G, Knight KM, Mayer D, Kuo JS, Lui NS.

J Infect Dis. 1984 Jun;149(6):950-5.

PMID:
6376656
29.

Tuberculin skin testing in Vietnamese refugees with a history of BCG vaccination.

Fox AS, Lepow ML.

Am J Dis Child. 1983 Nov;137(11):1093-4.

PMID:
6637913
30.

Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.

Lepow ML, Gold R.

N Engl J Med. 1983 May 12;308(19):1158-60. No abstract available.

PMID:
6403865
31.

Acrodermatitis in breast-fed premature infants: evidence for a defect of mammary zinc secretion.

Zimmerman AW, Hambidge KM, Lepow ML, Greenberg RD, Stover ML, Casey CE.

Pediatrics. 1982 Feb;69(2):176-83.

PMID:
7199132
32.

Long-term follow-up of persons inadvertently inoculated with SV40 as neonates.

Mortimer EA Jr, Lepow ML, Gold E, Robbins FC, Burton GJ, Fraumeni JF Jr.

N Engl J Med. 1981 Dec 17;305(25):1517-8. No abstract available.

PMID:
6272114
34.

Meningococcal group Y pneumonia in an adolescent female.

Hersh JH, Gold R, Lepow ML.

Pediatrics. 1979 Aug;64(2):222-4.

PMID:
112573
35.
36.

Enteroviral meningitis: A reappraisal.

Lepow ML.

Pediatrics. 1978 Aug;62(2):267-9. No abstract available.

PMID:
693167
37.

"Should she or shouldn't she" receive the rubella immunization before age 12.

Lepow ML, Quintiliani R.

Conn Med. 1978 Jun;42(6):403-4. No abstract available.

PMID:
11643459
38.

Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.

Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M.

J Infect Dis. 1978 Feb;137(2):112-21.

PMID:
415097
39.
40.

Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines.

Lepow ML, Goldschneider I, Gold R, Randolph M, Gotschlich EC.

Pediatrics. 1977 Nov;60(5):673-80.

PMID:
411104
41.

Further conquest of the meningococcus.

Lepow ML, Gold R.

N Engl J Med. 1977 Sep 29;297(13):721-2. No abstract available.

PMID:
408684
42.

Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.

Gold R, Lepow ML, Goldschneider I, Gotschlich EC.

J Infect Dis. 1977 Aug;136 Suppl:S31-5. No abstract available.

PMID:
408431
43.

The influence of environmental factors on maternal and neonatal blood lead levels.

Osborne RG, Raye JR, Bowers GN, Lepow ML.

Conn Med. 1976 Jul;40(7):452-5. No abstract available.

PMID:
954421
44.

Present status of polysaccharide vaccines in the prevention of meningococcal disease.

Gold R, Lepow ML.

Adv Pediatr. 1976;23:71-93. No abstract available.

PMID:
12651
45.

Investigations into sources of lead in the environment of urban children.

Lepow ML, Bruckman L, Gillette M, Markowitz S, Robino R, Kapish J.

Environ Res. 1975 Dec;10(3):415-26. No abstract available.

PMID:
1213021
46.

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.

Gold R, Lepow ML, Goldschneider I, Draper TL, Gotschlich EC.

J Clin Invest. 1975 Dec;56(6):1536-47.

47.

Measles immunization status in 1972 among first- and second-grade school children in Danbury, Connecticut.

Lepow ML, Steele FM, Ross MR, Randolph MF.

Pediatrics. 1975 Mar;55(3):348-53.

PMID:
806881
48.

Current status of vaccines against the meningococcus.

Lepow ML, Gold R.

Prev Med. 1974 Dec;3(4):449-55. No abstract available.

PMID:
4438280
49.

Role of airborne lead in increased body burden of lead in Hartford children.

Lepow ML, Bruckman L, Rubino RA, Markowtiz S, Gillette M, Kapish J.

Environ Health Perspect. 1974 May;7:99-102.

50.

Epidemiology of lead poisoning. A comparison between urban and rural children.

Cohen CJ, Bowers GN, Lepow ML.

JAMA. 1973 Dec 17;226(12):1430-3. No abstract available.

PMID:
4800808

Supplemental Content

Loading ...
Support Center